The relation between urinary sodium excretion (NaE) and renal tubular calcium reabsorption (TmCa/GFR) was assessed in patients with hypercalcaemia associated with malignancy and primary hyperparathyroidism. On acute saline loading of seven normally hydrated patients with primary hyperparathyroidism and five patients with malignancy, raised values of TmCa/GFR were reduced to normal in most cases, in association with increases in NaE. The reduction in TmCa/GFR, which occurred, may have been due to a reduction in proximal tubular calcium reabsorption associated with sodium: this would have obscured the effect of humorally mediated increases in distal tubular calcium reabsorption, which are stimulated either by parathyroid hormone or by a putative humoral mediator in hypercalcaemia of malignancy.
SUMMARY
The relation between urinary sodium excretion (NaE) and renal tubular calcium reabsorption (TmCa/GFR) was assessed in patients with hypercalcaemia associated with malignancy and primary hyperparathyroidism. On acute saline loading of seven normally hydrated patients with primary hyperparathyroidism and five patients with malignancy, raised values of TmCa/GFR were reduced to normal in most cases, in association with increases in NaE. The reduction in TmCa/GFR, which occurred, may have been due to a reduction in proximal tubular calcium reabsorption associated with sodium: this would have obscured the effect of humorally mediated increases in distal tubular calcium reabsorption, which are stimulated either by parathyroid hormone or by a putative humoral mediator in hypercalcaemia of malignancy.
In patients who were normally hydrated NaE and TmCa/GFR were not significantly correlated. When data were included from patients who were dehydrated and from those undergoing acute saline loading, significant inverse correlations between NaE and TmCa/GFR were observed both in primary hyperparathyroidism (r = -049; p < 002) and malignancy (r = -060; p < 0-001).
In clinical practice changes in TmCa/GFR associated with sodium seem to be of minor importance under normal circumstances, but they become evident at the upper and lower extremes of urinary sodium excretion. In clinical studies of renal calcium handling urinary sodium excretion must also be assessed, as interpreting TmCa/GFR data is difficult in states of excessive sodium loading or depletion.
We recently suggested that in some patients with hypercalcaemia associated with malignancy a humoral mediator is released which possesses a "PTH like" effect on renal tubular calcium reabsorption.'
These findings differ from those of previous workers who have generally considered that the humoral substance causing such hypercalcaemia may be distinguished from parathyroid hormone by its lack of effect on renal calcium handling.2 -In these earlier studies renal tubular calcium reabsorption was often found to be increased before sodium repletion, but was subsequently reduced to normal, and this feature was interpreted as evidence against a renal tubular action of the putative humoral mediator that causes hypercalcaemia.45
In our study' and in another recent study6 the renal tubular reabsorption of calcium remained increased Accepted for publication 16 January 1986 after rehydration, suggesting that changes in renal calcium handling may indeed have been caused by the action of such a humoral mediator. The reasons for the discrepancies between these studies are at present unclear but they may relate to differences in the degree of sodium repletion. In some studies tubular calcium reabsorption was measured after sodium repletion with intravenous sodium chloride solution 09% (saline) 2 litres daily,' 6 whereas in other studies much larger quantities of saline (up to 4 litres daily) were infused,4 5 or rehydration procedures were not specified. Twenty seven of these patients were studied after rehydration with 0 9% sodium chloride solution (saline) 2 litres daily, which had been routinely administered over a minimum period of 48 hours before study to correct possible sodium depletion. These patients were recorded as having stable serum creatinine values to within 5 pmol/l (0O05 mg/l00 ml)
for at least 24 hours before and after the study. Serum creatinine values were normal in most cases and comRalston, Gardner, Dryburgh, Cowan, Boyle parable with those in primary hyperparathyroidism (81.9 (4.9) pmol/l (0 90 (005) mg/100ml). Creatinine concentrations were raised in three cases (150, 150, 190 ,mol/I (1 65, 1 -65, 2X09 mg/100 ml), respectively).
Serum albumin values were generally reduced in these patients when compared with those with primary hyperparathyroidism 29-6 (0178) imol/l p < 0 01. A further four patients who presented with hypercalcaemia and dehydration were studied before receiving intravenous fluids. The remaining five patients had presented with stable hypercalcaemia and renal function, which had been documented for at least four weeks before the study. These patients were considered to be normally hydrated on clinical and biochemical grounds at the time of study, and hydration was maintained by a high oral fluid intake alone (> 2 litres daily). In these subjects further studies were performed during saline infusions and subsequent administration of antiosteoclastic drugs.
SALINE INFUSION STUDIES
All patients were permitted free oral fluids and received a normal hospital diet throughout the study. In patients with primary hyperparathyroidism infusions of saline were started shortly after collection of the baseline samples on day one and were subsequently continued for 48 hours. The rate of infusion was 500 ml every four hours (450 mmol (450 mEq) > sodium chloride daily).
In patients with hypercalcaemia of malignancy saline infusions were started after collection of baseline samples on day minus 3. The rate of infusion was 500 ml four hourly until day minus 1, and subsequently 500 ml six hourly until day plus 3. On day 0 patients were treated with the osteoclast inhibitors; aminohydroxypropylidene diphosphonate (APD) 15mg daily on days 0-6, or mithramycin 25 pg/kg intravenously on day 0 and day plus 3 (one patient). It is recognised that the hypocalcaemic effect of these drugs principally depends on reducing bone resorption, rather than as the result of changes in renal calcium handling.'3 14 BIOCHEMICAL METHODS Biochemical analyses were performed using a multichannel autoanalyser (Technicon) on fasting blood samples and true fasting urine samples, as described previously.' Total serum calcium was adjusted for albumin concentration to give an "adjusted" calcium value that was used subsequently throughout the study.'5 Urinary sodium excretion was expressed as NaE (NaE = urine sodium, divided by urine creatinine, multiplied by serum creatinine mmol/I GF (mEq/l GF)), and as the ratio of sodium clearance to creatinine clearance (ClNa:C1cr = urine sodium divided by urine creatinine, multiplied by serum cre-Urinary sodium excretion in hypercalcaemia atinine, divided by serum sodium). Renal tubular reabsorption of calcium was determined from fasting blood and urine samples using a nomogram to give the notional renal calcium threshold TmCa/GFR."6 Calcium excretion was also expressed as the ratio of calcium clearance to creatinine clearance (ClcaClcr = urine calcium divided by urine creatinine, multiplied by serum creatinine, divided by serum calcium). Serum parathyroid hormone was measured using a radioimmunoassay as described previously.'
Statistical analysis was carried out using the Wilcoxon test for paired samples, and Spearman's rank correlation coefficient.
Results
In 30 patients with primary hyperparathyroidism who were clinically normally hydrated there was no significant correlation between NaE and TmCa/GFR (r = 0-27; p > 0 05). When NaE and TmCa/GFR data were included from seven of these patients during saline infusions (two values in each patient (from days 1 and 2) (Fig. 1) ; total = 14 values) and from one additional patient who was clinically dehydrated (one value), NaE and TmCa/GFR were significantly correlated (r = -0-49; p < 0-002) (Fig. 2) .
In 27 patients with hypercalcaemia of malignancy studied during infusion of saline 2 litres daily NaE and TmCa/GFR were not significantly correlated (r = -0 16; p > 0-05). When NaE and TmCa/GFR data were included from the five normally hydrated patients with hypercalcaemia associated with malignancy during saline infusions of 3 litres daily (one value in each patient from day minus 1 (Fig. 1) ; total = five values), and from the four patients who were clinically dehydrated (four values), there was a significant correlation (r = -0-60; p < 0-001) (Fig. 3) .
In hyperparathyroid patients two values were included during saline infusions compared with only one in patients with hypercalcaemia of malignancy. The reason for this was simply because two measurements were made in hyperparathyroid patients during saline infusions (3 litres) daily compared with only one in the group with malignancy.
In the 12 patients undergoing further studies during saline infusion NaE and TmCa/GFR were not significantly correlated before infusion of saline was started, either in primary hyperparathyroidism (n = 7, r = -0-23, p > 0.05), or in malignancy (n = 5, r = -0 17; p > 0 05). Similarly, renal sodium clearance (ClNa:ClCF) and calcium clearance (ClcaClcr) did not correlate at this stage in either group (n = 7, r = 0-20, p > 0-05; n = 5, r = 0-15, p > 0-05). hyperparathyroidism and malignancy. In primary hyperparathyroidism rises in NaE and falls in TmCa/GFR and serum calcium were observed during infusion of saline (days I and 2). These changes reversed after saline infusions were stopped and most of the above variables had returned towards their basal values by days 3 and 4. There was a highly significant inverse correlation between NaE and TmCa/GFR values during days 0-3 of the study (28 pairs of observations r = -0-72; p < 0-001) and a positive correlation between (ClN":Clcr) and (Clca:Clcr); (r = 0-73; p < 0.001). (Fig.4) . Serum creatinine values were not significantly affected by the saline infusions, however, (mean (SEM) serum creatinine was 73*5 (7.4) .mol/l (0-80 (0-08) mg/l00ml) v 72-1 In hypercalcaemia of malignancy a similar pattern of response was observed: significant rises in NaE and falls in TmCa/GFR were observed on day minus 1, by which time patients had received 6 litres of saline and were continuing to receive saline infusions at the rate of 500 ml/4 hours. On the day of antiosteoclast treatment NaE had tended to fall and TmCa/GFR rise, as the rate of saline infusion was reduced to 500 ml/6 hours. Following antihypercalcaemic treatment further falls in NaE and rises in TmCa/GFR occurred as (Figs. 2 and 3 ). This suggests that in these circumstances sodium independent (and possibly humoral) changes in renal tubular reabsorption were of primary importance" determining TmCa/GFR.
In clinically dehydrated patients with both malignancy and primary hyperparathyroidism TmCa/ GFR was invariably raised, presumably as the result of increased sodium linked calcium reabsorption in the proximal tubule11 (Figs. 2 and 3) . Conversely, under conditions of acute sodium loading with intravenous saline (3 litres daily) there was a positive correlation between the rise in urinary sodium excretion and the fall in TmCa/GFR, suggesting that decreased sodium related calcium reabsorption in the proximal 7 -10-tubule was a major factor in changing the rate of renal tubular calcium reabsorption. Taken together, these findings suggest that sodium related changes in net renal tubular calcium reabsorption are of relatively minor importance under conditions of normal hydration but become evident at the upper and lower extremes of urinary sodium excretion.
In two previous studies of renal tubular calcium reabsorption in hypercalcaemia associated with malignancy, tubular calcium reabsorption was often raised before saline repletion but was generally reduced to normal afterwards.4" These findings were construed as evidence against a renal tubular action of the putative humoral mediator causing hypercalcaemia. Our data suggest that such conclusions are invalid, however, as although reductions in TmCa/GFR were observed during saline infusions in our patients with hypercalcaemia of malignancy, they were also observed in primary hyperparathyroidism, a condition in which a parathyroid hormone mediated rise in renal tubular calcium handling is known to exist." 12 It is apparent from these data that even moderate degrees of sodium loading can cause clinically important reductions in net renal tubular calcium reabsorption, even in the presence of a humorally mediated increase in distal tubular reabsorption.
It is difficult to put a precise value on the amount of urinary sodium excretion that would be expected to 645 cause clinically important changes in TmCa/GFR from our data. Such effects, however, seem to predominate at the upper and lower extremes of urinary sodium excretion (NaE > 5 mmol/1 (MEq/l) GF:NaE < 0 10mmol/l (MEq/l) GF). In the studies of hypercalcaemia associated with malignancy cited above45 renal tubular calcium reabsorption was generally assessed at the values of sodium excretion, which were raised, when compared with our normally hydrated patients; thus in one study median NaE was 4.9 mmol/l:GF (MEq/lGF) and the other 5-8 mmol/l:GF (MEq/l GF); this suggests that the "normal" TmCa/GFR values observed in some cases may, in fact, have largely been the result of a sodium related reduction in proximal tubular calcium reabsorption and as such did not exclude a concomitant increase in humorally mediated distal tubular calcium reabsorption.
From the clinician's point of view assessment of TmCa/GFR under conditions of normal sodium balance is desirable in hypercalcaemic disorders for diagnostic and therapeutic purposes. '7 Our data re-emphasise the importance of measuring sodium excretion in any investigation of renal tubular calcium reabsorption.'0 Moreover, we suggest that caution must be exercised in the interpretation of renal tubular calcium reabsorption data in patients who are excessively loaded with or depleted of sodium.
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